1
|
Manjunatha V, Nixon JE, Mathis GF, Lumpkins BS, Güzel-Seydim ZB, Seydim AC, Greene AK, Jiang X. Combined Effect of Nigella sativa and Kefir on the Live Performance and Health of Broiler Chickens Affected by Necrotic Enteritis. Animals (Basel) 2024; 14:2074. [PMID: 39061536 PMCID: PMC11273500 DOI: 10.3390/ani14142074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2024] [Revised: 07/10/2024] [Accepted: 07/12/2024] [Indexed: 07/28/2024] Open
Abstract
Coccidiosis and necrotic enteritis (NE) are prevalent poultry ailments worldwide, leading to decreased live performance and elevated mortality rates without antibiotic usage. This study evaluated Nigella sativa (black cumin) seeds (BCS) and kefir as alternatives to antibiotics for broilers. An in vivo study over a 28-day period, using 384 Cobb 500 male broilers organized into six treatment groups as part of a completely randomized block experimental design was conducted. Each treatment group included eight replicates, with each replicate containing eight birds. The treatments included positive control, negative control, antibiotic control, 5% BCS in feed, 20% kefir in drinking water, and a combination of 5% BCS and 20% kefir. NE was induced in broilers by administering ~5000 oocysts of Eimeria maxima orally on day 14, followed by inoculation with about 108 CFU/mL of Clostridium perfringens (Cp) (strain Cp#4) on days 19, 20, and 21. Live performance metrics including feed intake, body weight gain, and feed conversion were assessed in broilers. Additionally, NE disease outcomes such as lesion scores, mortality rates, and Cp populations in cecum were determined during the study. The BCS, kefir, and the combination had no detrimental effect on broiler live performance. BCS-treated and combination groups had lower NE scores (p > 0.05) in comparison to the positive control and exhibited no significant difference (p > 0.05) from antibiotic control. Additionally, treatment groups and antibiotic control were not significantly different (p > 0.05) in mortality, whereas the BCS and kefir combination significantly reduced (p < 0.05) mortality to 14.1% compared to 31.3% for the positive control. C. perfringens vegetative cells significantly decreased (p < 0.05) in treatments with BCS, kefir, and their combination on days 22 and 28 compared to the positive control. On day 22, Cp sores were significantly lower (p < 0.05) for the kefir and combination treatments compared to the positive control. In conclusion, BCS and kefir successfully reduced C. perfringens infection and mortality without any detrimental impact on broiler live performance with the combined treatment being the most effective. These results suggest that BCS and kefir could serve as potential alternatives to antibiotics in managing NE.
Collapse
Affiliation(s)
- Vishal Manjunatha
- Department of Food, Nutrition and Packaging Sciences, Clemson University, Clemson, SC 29631, USA;
| | - Julian E. Nixon
- Department of Animal and Veterinary Sciences, Clemson University, Clemson, SC 29631, USA; (J.E.N.); (G.F.M.); (B.S.L.); or (Z.B.G.-S.); or (A.C.S.); (A.K.G.)
| | - Greg F. Mathis
- Department of Animal and Veterinary Sciences, Clemson University, Clemson, SC 29631, USA; (J.E.N.); (G.F.M.); (B.S.L.); or (Z.B.G.-S.); or (A.C.S.); (A.K.G.)
- Southern Poultry Feed & Research, Inc., Athens, GA 30607, USA
| | - Brett S. Lumpkins
- Department of Animal and Veterinary Sciences, Clemson University, Clemson, SC 29631, USA; (J.E.N.); (G.F.M.); (B.S.L.); or (Z.B.G.-S.); or (A.C.S.); (A.K.G.)
- Southern Poultry Feed & Research, Inc., Athens, GA 30607, USA
| | - Zeynep B. Güzel-Seydim
- Department of Animal and Veterinary Sciences, Clemson University, Clemson, SC 29631, USA; (J.E.N.); (G.F.M.); (B.S.L.); or (Z.B.G.-S.); or (A.C.S.); (A.K.G.)
- Department of Food Engineering, Süleyman Demirel University, Isparta 32260, Turkey
| | - Atif C. Seydim
- Department of Animal and Veterinary Sciences, Clemson University, Clemson, SC 29631, USA; (J.E.N.); (G.F.M.); (B.S.L.); or (Z.B.G.-S.); or (A.C.S.); (A.K.G.)
- Department of Food Engineering, Süleyman Demirel University, Isparta 32260, Turkey
| | - Annel K. Greene
- Department of Animal and Veterinary Sciences, Clemson University, Clemson, SC 29631, USA; (J.E.N.); (G.F.M.); (B.S.L.); or (Z.B.G.-S.); or (A.C.S.); (A.K.G.)
| | - Xiuping Jiang
- Department of Food, Nutrition and Packaging Sciences, Clemson University, Clemson, SC 29631, USA;
| |
Collapse
|
2
|
Kurowska N, Madej M, Strzalka-Mrozik B. Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer. Curr Issues Mol Biol 2023; 46:121-139. [PMID: 38248312 PMCID: PMC10814900 DOI: 10.3390/cimb46010010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 12/18/2023] [Accepted: 12/21/2023] [Indexed: 01/23/2024] Open
Abstract
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and is responsible for approximately one million deaths each year. The current standard of care is surgical resection of the lesion and chemotherapy with 5-fluorouracil (5-FU). However, of concern is the increasing incidence in an increasingly younger patient population and the ability of CRC cells to develop resistance to 5-FU. In this review, we discuss the effects of thymoquinone (TQ), one of the main bioactive components of Nigella sativa seeds, on CRC, with a particular focus on the use of TQ in combination therapy with other chemotherapeutic agents. TQ exhibits anti-CRC activity by inducing a proapoptotic effect and inhibiting proliferation, primarily through its effect on the regulation of signaling pathways crucial for tumor progression and oxidative stress. TQ can be used synergistically with chemotherapeutic agents to enhance their anticancer effects and to influence the expression of signaling pathways and other genes important in cancer development. These data appear to be most relevant for co-treatment with 5-FU. We believe that TQ is a suitable candidate for consideration in the chemoprevention and adjuvant therapy for CRC, but further studies, including clinical trials, are needed to confirm its safety and efficacy in the treatment of cancer.
Collapse
Affiliation(s)
- Natalia Kurowska
- Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland; (N.K.); (M.M.)
| | - Marcel Madej
- Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland; (N.K.); (M.M.)
- Silesia LabMed, Centre for Research and Implementation, Medical University of Silesia, 40-752 Katowice, Poland
| | - Barbara Strzalka-Mrozik
- Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland; (N.K.); (M.M.)
| |
Collapse
|